Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beihai Guofa Chuanshan Biological Pharmaceutical is a Chinese life sciences company specializing in marine-derived biological products and traditional Chinese medicine. Based in Beihai, Guangxi, the company focuses on the research, development, and commercialization of pharmaceuticals, including its signature pearl-based calcium supplements. Its product portfolio spans various therapeutic areas such as bone health, cardiovascular conditions, and digestive health, offered in multiple dosage forms like tablets and capsules. The company is vertically integrated, maintaining its own manufacturing facilities that comply with national GMP standards. As a publicly traded entity on the Shanghai Stock Exchange, it plays a significant role in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beihai Guofa Chuanshan Biological Pharmaceutical.